🕵️ Calidi Biotherapeutics, Inc. ($CLDI)
SEC insider & ownership activity, last 12 months · CIK 1855485 · every row links its SEC filing
Over the last 12 months insiders sold $1K against $455K of open-market buying. Leftwich Scott bought $250K in discretionary trades (Aug). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
4 buyers, $455K (8 lots) · 1 seller, $1K (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Leftwich Scott | 2 | $250K | 0 | – | Aug 21, 2025 |
| James A. Schoeneck | 2 | $150K | 0 | – | Aug 21, 2025 |
| Eric E. Poma | 2 | $50K | 0 | – | Aug 21, 2025 |
| Andrew C. Jackson | 2 | $5K | 0 | – | Aug 21, 2025 |
| Camaisa Allan | 0 | – | 1 | $1K | Dec 12, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| Steven Boyd | 10.0% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jul 10, 2026 | filing ↗ |
| Agreement terminated (1.02) | Jul 10, 2026 | filing ↗ |
| New financial obligation (2.03) | Jul 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 17, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 17, 2026 | filing ↗ |
| Other events (8.01) | Jun 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 17, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 12, 2026 | filing ↗ |
| Material agreement (1.01) | May 28, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | May 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 28, 2026 | filing ↗ |
| Earnings (2.02) | May 14, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Material agreement (1.01) | May 6, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 29, 2026 | filing ↗ |
| Other events (8.01) | Mar 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 29, 2026 | filing ↗ |
| Earnings (2.02) | Mar 27, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 27, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 5, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 5, 2026 | filing ↗ |
| Other events (8.01) | Mar 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 6, 2026 | filing ↗ |